Fulcrum Therapeutics, INC. (FULC) SEC Filings — 2025

Filings

• Fulcrum Therapeutics Enters Material Definitive Agreement — 8-K · Dec 11, 2025
• Fulcrum Therapeutics Files 8-K — 8-K · Dec 8, 2025
• Fulcrum's Losses Mount to $54.5M Amidst Zero Collaboration Revenue — 10-Q · Oct 29, 2025
• Fulcrum Therapeutics, INC. 8-K Filing — 8-K · Aug 28, 2025
• Fulcrum's Q2 Loss Widens Amid Soaring R&D Costs — 10-Q · Jul 29, 2025
• Fulcrum Therapeutics Files 8-K on Shareholder Vote — 8-K · Jun 27, 2025
• Fulcrum Therapeutics Files Q1 2025 10-Q — 10-Q · May 1, 2025
• Fulcrum Therapeutics Executive Compensation Details — DEF 14A · Apr 30, 2025
• Fulcrum Therapeutics Terminates Material Definitive Agreement — 8-K · Mar 4, 2025
• Fulcrum Therapeutics Files 2024 10-K — 10-K · Feb 25, 2025
• Sanofi to Acquire Fulcrum Therapeutics for $805M — 8-K · Jan 13, 2025